Found: 6
Select item for more details and to access through your institution.
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Targeting myeloid-derived suppressor cells for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1181, doi. 10.1007/s00262-018-2175-3
- By:
- Publication type:
- Article
Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e138, doi. 10.1016/j.clml.2017.03.250
- By:
- Publication type:
- Article
Immortalized B Cells Transfected with mRNA of Antigen Fused to MITD (IBMAM): An Effective Tool for Antigen-Specific T-Cell Expansion and TCR Validation.
- Published in:
- Biomedicines, 2023, v. 11, n. 3, p. 796, doi. 10.3390/biomedicines11030796
- By:
- Publication type:
- Article
Corrigendum to "Prime-Boost Vaccination Using Chemokine-Fused gp120 DNA and HIV Envelope Peptides Activates Both Immediate and Long-Term Memory Cellular Responses in Rhesus Macaques".
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/5471638
- By:
- Publication type:
- Article
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50880-2
- By:
- Publication type:
- Article